A cell-permeable activator of Wnt signaling
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Wnt Agonist I

Item No. 19903

Technical Information
Formal Name
N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-2,4-pyrimidinediamine
CAS Number
853220-52-7
Synonyms
  • BML-284
Molecular Formula
C19H18N4O3
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 30 mg/mlDMSO: 10 mg/mlEthanol: 0.14 mg/ml
λmax
215, 294 nm
SMILES
COC1=CC=CC(C2=CC(NCC3=CC=C(OCO4)C4=C3)=NC(N)=N2)=C1
InChi Code
InChI=1S/C19H18N4O3/c1-24-14-4-2-3-13(8-14)15-9-18(23-19(20)22-15)21-10-12-5-6-16-17(7-12)26-11-25-16/h2-9H,10-11H2,1H3,(H3,20,21,22,23)
InChi Key
FABQUVYDAXWUQP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Wnt Agonist I is a cell-permeable activator of Wnt signaling that does not inhibit GSK3β (IC50 > 60 µM).1 It induces nuclear accumulation of β-catenin, increasing transcriptional activity driven by TCF (EC50 = 700 nM) and altering embryonic development.1,2 Wnt Agonist I is effective in vivo, decreasing tissue damage and improving renal function after ischemia-reperfusion in rats.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Liu, J., Wu, X., Mitchell, B., et alA small-molecule agonist of the Wnt signaling pathway. Agnew. Chem. Int. Ed. Engl. 44(13), 1987-1990 (2005).

    2. Lim, J.C., Kania, K.D., Wijesuriya, H., et alActivation of β-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J. Neurochem. 106(4), 1855-1865 (2008).

    3. Kuncewitch, M., Yang, W.-L., Corbo, L., et alWNT agonist decreases tissue damage and improves renal function after ischemia-reperfusion. Shock 43(3), 268-275 (2015).